Nordstrom, Inc. (NYSE:JWN) is rolling to end the week. The higher end retailer shares are up more than $8 after topping Wall Street's estimates and putting its $2B credit card receivables portfolio up for sale.
Nordstrom is a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for women, men, and children in the United States. It operates in two segments, Retail and Credit. The Retail segment offers a selection of brand name and private label merchandise. The Credit segment operates Nordstrom fsb, a federal savings bank, which provides a private label credit card, two Nordstrom VISA credit cards, and a debit card.
[Related -Nordstrom, Inc. (JWN) Q4 Earnings Preview: Trends Say Strong Quarter, But So What!]
A few brokers upped their opinions and price-targets on the fashion specialty retailer following the well-received announcement.
Top Clean Energy Stocks To Watch For 2015: AZZ Inc (AZZ)
AZZ incorporated, incorporated on March 29, 1956, is an electrical equipment and components manufacturer, serving the global markets of power generation, transmission and distribution, and the general industrial markets, and a provider of hot dip galvanizing services to the North American steel fabrication market. The Company operates in two segments: the Electrical and Industrial Products and Services Segment and the Galvanizing Services Segment. On October 1, 2012, the Company completed the acquisition of substantially all of the assets of Galvcast Manufacturing Inc. On January 2, 2013, the Company acquired G3 Galvanizing Limited (G3), a company with galvanizing operations in Halifax, Nova Scotia. On March 29, 2013, the Company completed its acquisition of Aquilex Specialty Repair and Overhaul LLC. In April 2013, it completed the acquisition of Aquilex Specialty Repair and Overhaul LLC (Aquilex SRO).
Electrical and Industrial Products and Services Segment
The Company�� Electrical and Industrial Products and Services Segment produces engineered specialty electrical products, industrial lighting and tubular products, all of which the Company market and sell both in domestic and international markets. The Company�� electrical products are designed, manufactured and configured to distribute electrical power to and from generators, transformers, switching devices and other electrical configurations and are supplied to the power generation, transmission and distribution markets and the general industrial market. The Company�� industrial products include industrial lighting and tubular products. The Company provides lighting products to the petroleum and food processing industries, and to other industries with lighting challenges. The Company also provides tubular products to the petroleum industry. In addition, the Company�� Electrical and Industrial Products and Services Segment provide electrical and mechanical equipment and services enhancing the safety of nuclear faci! lities.
Galvanizing Services Segment
The Galvanizing Services Segment provides hot dip galvanizing to the steel fabrication industry through facilities located throughout the South, Midwest, East Coast and Southwest of the United States and in the Canadian provinces of Quebec, Ontario and Nova Scotia. Hot dip galvanizing is a metallurgical process in which molten zinc is applied to a customer�� material. As of February 28, 2013, the Company operated thirty-five galvanizing plants, which are located in Alabama, Arkansas, Arizona, Colorado, Indiana, Illinois, Louisiana, Kentucky, Minnesota, Mississippi, Missouri, Ohio, Oklahoma, Tennessee, Texas, Virginia and West Virginia in the United States and Ontario, Quebec and Nova Scotia in Canada. The Company serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical and general industrial markets, and numerous original equipment manufacturers.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of electrical equipment maker AZZ (NYSE: AZZ ) dropped as much as 16% today after the company reported earnings.
So what: Revenue was up 44%, to $183.2 million, but net income fell 9%, to $14.5 million, or $0.57 per share. Analysts expected $197.6 million in revenue and $0.63 in earnings, so the quarter fell well short of expectations.�
Top 10 Heal Care Stocks For 2014: BBVA Banco Frances S.A. (BFR)
BBVA Banco Franc茅s S.A., together with its subsidiaries, provides various financial services to corporations, medium and small companies, and individual customers in the Republic of Argentina. The company offers checking and savings accounts, time deposits, and investment accounts. It also provides short and long-term loans to companies, overdraft lines of credit, discounted instruments, loans to financial institutions and the governmental sector, collateral loans, and real estate mortgage, as well as consumer loans comprising credit card loans and other consumer loans. In addition, the company offers home and personal accident insurance; payroll services; asset management services; and insurance advisory services to customers in the areas of coverage of risks related to life, personal accidents and home insurance, and automated teller machine (ATM) robbery insurance. Further, it provides foreign trade services, including letters of credit, collections, bank drafts, fund transfers, and foreign currency transactions; and electronic banking, ATM, self-service terminals, Internet and mobile banking, call center, and trust services. Additionally, the company engages in capital market and securities activities, principally underwriting and placement of corporate bonds, commercial paper, and equity securities; corporate advisory; and securities brokerage. As of December 31, 2011, it operated 268 branches comprising 240 retail branches, 28 branches specialized in small and medium enterprises segment, 13 in-company branches, 7 corporate banking units, and 3 points of sale, as well as 654 ATM�s and 695 quick deposit boxes. The company was formerly known as Banco Frances del Rio de la Plata S.A. and changed its name to BBVA Banco Franc茅s S.A. in October 2000. The company was founded in 1886 and is based in Buenos Aires, the Republic of Argentina. BBVA Banco Franc茅s SA operates as a subsidiary of Banco Bilbao Vizcaya Argentaria, S.A.
Advisors' Opinion:- [By Federico Zaldua]
Banco Frances (BFR), 75% controlled by Banco Bilbao Viscaya Argentaria, is among the biggest banks in Argentina. The bank has the smallest exposure to Argentina's public debt out of the three banks analyzed in the article and presents the lowest pace of growth. That said, its one of the healthiest banks in the country given that it has the lowest NPL ratio and the highest reserve ratio to absorb potential losses. The bank also trades cheaply at 3.5 times P/E and 85% its book value. Being more expensive (although still very cheap relative to the sector's average) and with the lowest liquidity among this group of three, I would exclude Banco Frances from my Argentinean bank portfolio.
Top 10 Heal Care Stocks For 2014: CEVA Inc.(CEVA)
CEVA, Inc., together with its subsidiaries, engages in licensing silicon intellectual property (SIP) for the handsets, mobile broadband, portable, and consumer electronics markets primarily in the United States, Europe, the Middle East, and the Asia Pacific. It designs and licenses DSP cores in the form of a hardware description language definition; a portfolio of application-specific platforms, including wireless baseband, audio, imaging and vision, voice over Internet protocols (VoIP), Bluetooth, and serial storage technology and serial attached SCSI; and development platforms, software development kits, and software debug tools that facilitate system design, debug, and software development. The company?s intellectual property (IP) is used by semiconductor and original equipment manufacturer companies for application-specific integrated circuits and application-specific standard products. It serves various markets, including feature phones, smartphones, machine to machi ne for various cellular standards, home entertainment, portable game consoles, and serial storage and telecommunication devices. CEVA, Inc. markets its technology through a direct sales force. The company was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. CEVA, Inc. was founded in 1999 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CEVA (Nasdaq: CEVA ) , whose recent revenue and earnings are plotted below.
Top 10 Heal Care Stocks For 2014: Macy’s Inc (M)
Macy�s, Inc., together with its subsidiaries, operates stores and Internet Websites in the United States. Its retail stores and Internet Web sites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates Bloomingdale�s Outlet stores that offer a range of apparel and accessories, including ready-to-wear, shoes, fashion accessories, jewelry, handbags, and intimate apparel products. As of January 28, 2012, it operated approximately 840 stores under the names of Macy�s and Bloomingdale�s; and 7 Bloomingdale�s Outlet stores, as well as macys.com and bloomingdales.com. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy�s, Inc. in June 2007. Macy�s, Inc. was founded in 1820 and is based in Cincinnati, Ohio.
Advisors' Opinion:- [By Anh HOANG]
Recently, Bed Bath & Beyond (NASDAQ: BBBY ) experienced a significant drop of as much as 13% due to its disappointing full-year outlook. After the drop, Bed Bath & Beyond is valued at only 13 times its forward earnings. Should investors stay away from the company because of the sluggish earnings outlook, or�is Bed Bath & Beyond a better buy with its lower market price than larger peers such as Target (NYSE: TGT ) and Macy's (NYSE: M ) ?
- [By Steve Symington]
What's more, competitors like Macy's (NYSE: M ) and Nordstrom (NYSE: JWN ) �seemed to be firing on all cylinders last quarter�by�increasing�same-store sales, boosting dividends, and instituting huge share repurchase programs.
- [By Jake L'Ecuyer]
Top Headline
Macy's (NYSE: M) reported a rise in its third-quarter profit.Macy's quarterly profit surged to $177 million, or $0.47 per share, versus a year-ago profit of $145 million, or $0.36 per share.
- [By Alyssa Oursler]
The outlook for the broader retail sector — peppered by bad news from generally successful companies such as Macy’s (M) and�Walmart (WMT) — has been murky lately, leaving little hope hope for a bleeding retailer like Penney.�The company supposedly is considering raising more capital, and analysts already are saying that it had a weak back-to-school shopping season. Shocker.
Top 10 Heal Care Stocks For 2014: West Pharmaceutical Services Inc.(WST)
West Pharmaceutical Services, Inc. manufactures and sells components and systems for injectable drug delivery and plastic packaging, and delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company?s Packaging Systems segment provides packaging components and systems used in injectable drug delivery. This segment offers elastomeric stoppers and discs, elastomeric plungers, needle shields, tip caps, aluminum seals and removable plastic buttons, elastomeric components, flashback bulbs and sleeve stoppers, elastomer and co-molded elastomer/plastic components, non-filled syringe components, and dropper bulbs, as well as pharmaceutical containers, closures, and dispensers. This segment also provides laboratory and other services comprising extractables and leachables testing, package/container testing, method development/validation, stability testing, process development, and problem resolution. Its Delivery Systems segment offer s healthcare devices, such as ready-to-use prefilled syringe systems and sterile vials. This segment also offers sterile devices and electronic patch injector systems; passive safety needle systems, disposable auto-injector systems, and safety systems for prefilled syringes; and contract manufacturing services for personal care and consumer products, including infant nurser assemblies, closures for beverage containers, and child-resistant and tamper-evident closures and dispensers. In addition, this segment engages in contract manufacturing and assembling injection molded components and devices for surgical, ophthalmic, diagnostic, and drug delivery systems. The company distributes its products through its sales force and distribution network, as well as through contract sales agents and regional distributors in the United States, Germany, France, and other European countries. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Lionville, Pennsylva nia.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on West Pharmaceutical Services (NYSE: WST ) , whose recent revenue and earnings are plotted below.
Top 10 Heal Care Stocks For 2014: SearchCore Inc (SRER)
SearchCore, Inc., formerly General Cannabis, Inc., incorporated in 2003, is a technology service provider. As of December 31, 2011, the Company was engaged in the medicinal cannabis industry. The Company assists the physicians, dispensaries, and end-users within the medicinal cannabis industry in finding each other and in advertising their businesses. All of its operations are conducted through its wholly owned subsidiaries. On January 5, 2012, WeedMaps, LLC (WeedMaps) acquired substantially all the assets of MMJMenu, LLC. On October 31, 2011, General Merchant Solutions, Inc. discontinued all retail credit card processing operations. On January 11, 2011, the Company acquired all the assets of Revyv, LLC. On December 31, 2012, the Company acquired Sports Asylum, Inc. In February 2013, it acquired ModularHomes.com.
WeedMaps Media, Inc. is its wholly owned subsidiary, and its primary operation is the Internet Website, www.weedmaps.com. WeedMaps.com is an online finder site service that allows patients to find local medical cannabis dispensaries, which are also referred to as collectives. Dispensaries are locations where patients who have received letters of recommendation from a healthcare provider can purchase medicinal cannabis, as well as a variety of other non-cannabis related items including, but not limited to, apparel accessories, posters, bumper stickers, concert tickets, books and musical compact disc�� (CD��).
General Marketing Solutions, Inc. is its wholly owned subsidiary, and its primary operation is the Internet Website, www.cannabiscenters.com. General Management Solutions, Inc. is its wholly owned subsidiary that oversees and provides all of the human resources issues for employees, including hiring, terminating and employee benefits. The Company has two additional wholly owned subsidiaries; General Processing Corporation, CannaCenters Corporation (CannaCenters), and two subsidiaries, namely LV Luxuries Incorporated (which operated as makeup.com) and General ! Health Solutions, Inc. (CannaCenters.com).
Advisors' Opinion:- [By Peter Graham]
Small cap communications or Internet stocks American Community Development Group Inc (OTCMKTS: ACYD), Globalstar, Inc (OTCMKTS: GSAT) and SearchCore Inc (OTCMKTS: SRER) have been rather quiet lately for investors after making some noise back in September. Nevertheless, all three are still getting some mentions in various investment newsletters or alerts and not because they are the subject of paid promotions. So are these small cap stocks about to make some noise? Here is a closer look:
Top 10 Heal Care Stocks For 2014: CEL-SCI Corp (CVM)
CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Multikine
CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.
New Manufacturing Facility
CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.
LEAPS
CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.
Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.
Advisors' Opinion:- [By James E. Brumley]
When biotech-savvy investors think of immunology stocks, they tend to gravitate towards a name like Dendreon Corporation (NASDAQ:DNDN), which for all intents and purposes introduced the world's first cancer vaccine, Provenge, as a treatment for prostate cancer. Traders with a better-than-average knowledge of the immunology field may turn their attention to a company like CEL-SCI Corporation (NYSEMKT:CVM). CEL-SCI doesn't have a product on the market yet, but its head and neck cancer drug - which also uses immunology - is in Phase 3 testing right now, and looks very promising. There are other, and smaller, stocks within the world of immunology, however, that deserve a closer look from the market, and one of the most exciting ones further down the size scale is TNI Biotech Inc. (OTCMKTS:TNIB).
No comments:
Post a Comment